Hear from Mark Socinski, MD, Director of UNC’s Thoracic Oncology Program, about the advances that have been made in lung cancer and what lung cancer patients need to know. Watch video. Photo credit: Rachel Garrison Hear from Taylor Bell, lung cancer survivor and Community Outreach Coordinator for Carolina Well at the Leo Jenkins Cancer … Read more
CHAPEL HILL, NC – Cycle 2010, a group of Boy Scouts and students from Chapel Hill who bicycled across the country this past summer to raise money for UNC Lineberger, were recipients of the Outstanding Youth in Philanthropy Award. The award was presented by the N.C. Triangle Chapter of the Association of Fundraising Professionals at … Read more
CHAPEL HILL, NC – On November 3, 2010, Lisa Carey, MD, was honored by the YWCA of the Greater Triangle as one of 11 new members at the 2010 Academy of Women Awards. Membership in the Academy of Women is a distinguished honor, recognizing remarkable women who excel in their fields while embodying the YWCA … Read more
Organization will receive The Artist in Residence Program to help people affected by cancer
CHAPEL HILL, NC – Four staff members were honored by UNC Lineberger Comprehensive Cancer Center with the 2010 Oncology Nursing Excellence Awards and the Clinical Services Excellence Awards. Ann Fletcher, Sam Sharf and Liz Sherwood each received a 2010 Oncology Nursing Excellence Award. Dan Roscicki was recognized with a Clinical Services Excellence Award. Dr. Richard … Read more
CHAPEL HILL, NC – The article “Calorie counting is not as easy as you think” written by Rose Pastore and published November 9, 2010 on MarketWatch, part of The Wall Street Digital network, quotes UNC Lineberger member Marci Campbell, PhD, MPH, RD. In the article, she talked about nutrition decisions and what factors impact these … Read more
CHAPEL HILL, NC – A new discovery by UNC scientists describes how cells infected by the Epstein-Barr virus (EBV) produce small vesicles or sacs called exosomes, changing their cellular “cargo” of proteins and RNA. This altered exosome enters cells and can change the growth of recipient cells from benign to cancer-producing. In this way, virus-infected … Read more
The article “U.S. Says Genes Should Not Be Eligible for Patents” written by Andrew Pollack and published in the October 29, 2010 issue of The New York Times quotes UNC Lineberger member Jim Evans, MD, PhD. He spoke about the federal government’s recent ruling regarding gene patenting. Dr. Evans is the director of clinical cancer … Read more
G-Zero Therapeutics funded under Qualifying Therapeutic Discovery Project
In a study published this month in the Journal of Clinical Oncology, the results of a clinical trial of the drug bevacizumab to treat colon cancer in combination with the standard therapy found that the drug did not significantly increase disease-free survival in patients with stage II and stage III colon cancer.
